World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
58
Citations
13411
World Ranking
13083
National Ranking
5580

Roberto Chiarle publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Roberto Chiarle sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 230 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Roberto Chiarle D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Roberto Chiarle sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 58 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Roberto Chiarle is affiliated with Harvard University in the United States and has an extensive publication record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work focuses significantly on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, and Immunology.

Their research covers various topics including Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, CAR-T cell therapy research, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, RNA modifications and cancer, and Neuroblastoma Research and Treatments.

Roberto Chiarle's frequent co-authors include Claudia Voena, Chiara Ambrogio, Taek-Chin Cheong, Carlo Gambacorti-Passerini, and Elisa Bergaggio.

The scientist has published frequently in the following venues:

  • Cancer Research
  • Blood
  • Nature Communications
  • Regular and Young Investigator Award Abstracts
  • Blood Advances

Recent papers by Roberto Chiarle reflect a focus on genetic editing technologies, cancer mechanisms, and microenvironment interactions. Examples include:

  • Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing, 2023, Nature Communications
  • ERα-associated translocations underlie oncogene amplifications in breast cancer, 2023, Nature
  • Frequency and mechanisms of LINE-1 retrotransposon insertions at CRISPR/Cas9 sites, 2022, Nature Communications
  • SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment, 2023, Cancer Discovery
  • Dissecting ELANE neutropenia pathogenicity by human HSC gene editing, 2021, Cell stem cell

Best Publications

  • The anaplastic lymphoma kinase in the pathogenesis of cancer.

    Roberto Chiarle;Claudia Voena;Chiara Ambrogio;Roberto Piva;Roberto Piva

  • Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing

    Nicola Crosetto;Abhishek Mitra;Maria Joao Silva;Magda Bienko;Magda Bienko

  • Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target

    Roberto Chiarle;William J Simmons;Honjying Cai;Girish Dhall

  • Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells

    Roberto Chiarle;Yu Zhang;Richard L. Frock;Susanna M. Lewis

  • Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death

    Alberto Zamo;Roberto Chiarle;Roberto Piva;Jennifer Howes

  • Role of the F-box protein Skp2 in lymphomagenesis.

    Esther Latres;Roberto Chiarle;Brenda A. Schulman;Nikola P. Pavletich

  • The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo

    Florian A. Karreth;Markus Reschke;Anna Ruocco;Christopher Ng

  • The STAT3 isoforms alpha and beta have unique and specific functions.

    Diego Maritano;Michelle L Sugrue;Michelle L Sugrue;Silvia Tininini;Sarah Dewilde

  • NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.

    Roberto Chiarle;Jerald Z. Gong;Ilaria Guasparri;Anna Pesci

  • FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas

    Shanshan Duan;Lukas Cermak;Julia K. Pagan;Mario Rossi

  • Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

    Roberto Chiarle;Leo M. Budel;Jeffrey Skolnik;Glauco Frizzera

  • Substitutions at codon 22 of Alzheimer's abeta peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells.

    Leticia Miravalle;Takahiko Tokuda;Roberto Chiarle;Giorgio Giaccone

  • KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.

    Chiara Ambrogio;Jens Köhler;Zhi Wei Zhou;Haiyun Wang

  • Simple and Rapid In Vivo Generation of Chromosomal Rearrangements using CRISPR/Cas9 Technology

    Rafael B Blasco;Elif Karaca;Chiara Ambrogio;Taek Chin Cheong

  • CD30 in normal and neoplastic cells.

    Roberto Chiarle;A Podda;G Prolla;J Gong

  • Mechanisms that Promote and Suppress Chromosomal Translocations in Lymphocytes

    Monica Gostissa;Frederick W. Alt;Roberto Chiarle

  • Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and Bcl2A1 as critical target genes

    Roberto Piva;Elisa Pellegrino;Michela Mattioli;Luca Agnelli

  • Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas

    Roberto Piva;Roberto Chiarle;Roberto Chiarle;Andrea D. Manazza;Andrea D. Manazza;Riccardo Taulli;Riccardo Taulli

  • New and old functions of STAT3: a pivotal target for individualized treatment of cancer.

    Giorgio Inghirami;Roberto Chiarle;William J Simmons;Roberto Piva

  • S-Phase Kinase-Associated Protein 2 Expression in Non-Hodgkin's Lymphoma Inversely Correlates with p27 Expression and Defines Cells in S Phase

    Roberto Chiarle;Yan Fan;Roberto Piva;Hugo Boggino

Frequent Co-Authors

Giorgio Inghirami
Giorgio Inghirami Cornell University
Francesco Novelli
Francesco Novelli University of Turin
Frederick W. Alt
Frederick W. Alt Boston Children's Hospital
Michele Pagano
Michele Pagano New York University
Emilio Hirsch
Emilio Hirsch University of Turin
Mirella Giovarelli
Mirella Giovarelli University of Turin
Federica Cavallo
Federica Cavallo University of Turin
Carlo Gambacorti-Passerini
Carlo Gambacorti-Passerini University of Milano-Bicocca
Ole Nørregaard Jensen
Ole Nørregaard Jensen University of Southern Denmark
Valeria Poli
Valeria Poli University of Turin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens the door to a wide range of online study and career options. Many students consider related fields such as nutrition, kinesiology, or advanced nursing for their professional development. Flexible online programs can help you gain certifications faster and align your education with modern workforce demands.

For those with interests in exercise science, an accelerated kinesiology degree online can provide specialized knowledge in human movement and fitness. If nutrition and health is your focus, a dietitian degree online can be a cost-effective way to enter a growing field.

Healthcare professionals often look into fast-track certifications. Options like the fastest post master's pmhnp for Psychiatric-Mental Health Nurse Practitioner, or the shortest post master's fnp program for Family Nurse Practitioner, can expand career prospects for those with existing advanced degrees.

Online learning makes it easier for busy individuals to build on their science background and achieve new career milestones. Explore these options to find the right path for your goals in the biosciences and healthcare sectors.

Best Scientists Citing Roberto Chiarle

Trending Scientists

Recently Published Articles